-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Coagulation Alterations in Hematologic Malignancies

Symposia: Scientific Workshop on the Interplay between Coagulation and Malignancy Program: Scientific Workshops
Friday, December 8, 2023: 2:05 PM-3:00 PM
Room 25 (San Diego Convention Center)
Moderator:
and Stephanie Lee, MD, MSc, FRCPC, University of Toronto/St. Michael's Hospital
Disclosures:
Lee: Medison: Consultancy.
Moderator Introduction

Stephanie Lee, MD, MSc, FRCPC

University of Toronto/St. Michael's Hospital, Toronto, Canada
Aberrant Platelet Activity in Myeloproliferative Neoplasms

Jorge Di Paola, MD

Washington University in St Louis, St Louis, MO
Platelet Proteome in Myeloproliferative Neoplasms

Sarah Kelliher

Haematology, Mater Misericordiae University Hospital, Dublin, Ireland
KLF2 and Hypercoagulability in Myeloproliferative Neoplasms

Josef T. Prchal, MD

Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
PF4 Antibodies in Monoclonal Gammopathy of Thrombotic Significance

Anand Pabmanabhan, MBBS, PhD

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
Panel Discussion
See more of: Scientific Workshop on the Interplay between Coagulation and Malignancy
See more of: Scientific Workshops
<< Previous Session | Next Session >>